Kestra Advisory Services LLC Purchases 8,903 Shares of SPDR S&P Pharmaceuticals ETF $XPH

Kestra Advisory Services LLC increased its position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 329.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 11,603 shares of the company’s stock after purchasing an additional 8,903 shares during the quarter. Kestra Advisory Services LLC’s holdings in SPDR S&P Pharmaceuticals ETF were worth $628,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Compass Wealth Management LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth approximately $992,000. UBS Group AG grew its holdings in shares of SPDR S&P Pharmaceuticals ETF by 33.2% in the fourth quarter. UBS Group AG now owns 47,961 shares of the company’s stock valued at $2,686,000 after acquiring an additional 11,948 shares in the last quarter. Private Advisor Group LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF during the first quarter valued at approximately $3,017,000. Orion Porfolio Solutions LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF during the fourth quarter valued at approximately $244,000. Finally, Vista Investment Management purchased a new position in SPDR S&P Pharmaceuticals ETF in the fourth quarter valued at about $223,000.

SPDR S&P Pharmaceuticals ETF Stock Down 0.8%

Shares of XPH stock opened at $67.95 on Friday. The company has a 50 day moving average of $62.65 and a 200-day moving average of $58.52. SPDR S&P Pharmaceuticals ETF has a 12-month low of $40.80 and a 12-month high of $70.15. The firm has a market cap of $472.25 million, a P/E ratio of 14.28 and a beta of 0.58.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.